Insiders · Profile

Hillsberg Sanford

Director at IOVANCE BIOTHERAPEUTICS · Director at SELLAS Life Sciences. Filing since 26 Mar 2010. CIK 0001297696

Company
Date
Role
Action
Shares
Amount
Of holding
22 Aug 2016
Director
Sold, plan not stated
54,000
$491.74K
35.1%
8 Sep 2015
Director
Sold, plan not stated
16,500
$117.65K
9.7%
4 Sep 2015
Director
Sold, plan not stated
16,000
$109.44K
8.6%
3 Aug 2015
Director
Sold, plan not stated
32,500
$264.88K
14.8%
6 May 2015
Director
Sold, plan not stated
50,000
$500.00K
18.6%
30 Jan 2014
Director
Sold, plan not stated
250,000
$1.35M
93.3%
17 Jan 2014
Director
Sold, plan not stated
200,000
$1.39M
64.4%
26 Mar 2010
Director
Sold, plan not stated
25,000
$141.50K
80.6%
8 decisions on file.